Henry F. Chambers
- Clinical Biochemistry top 0.01%
- Bacterial Identification and Susceptibility Testing 92
- Infectious Diseases top 0.01%
- Antimicrobial Resistance in Staphylococcus 170
- Applied Microbiology and Biotechnology top 0.05%
- Antibiotic Use and Resistance 23
- Molecular Medicine top 0.05%
- Antibiotic Resistance in Bacteria 55
- Microbiology top 0.1%
-
- Infective Endocarditis Diagnosis and Management 53
-
- Antibiotics Pharmacokinetics and Efficacy 47
-
- Streptococcal Infections and Treatments 40
-
- Bacterial biofilms and quorum sensing 34
- Co-authors
- Frank R. DeLeoSheldon L. KaplanCatherine LiuArnold S. BayerC J HackbarthMichaël OttoJames C. WadeSherwood L. Gorbach
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Henry F. Chambers
246 papers receiving 26.5k citations
Hit Papers
Peers
Comparison fields: 5 of 176
- Clinical Biochemistry 9.2k
- Infectious Diseases 19.0k
- Applied Microbiology and Biotechnology 1.6k
- Molecular Medicine 3.3k
- Microbiology 1.5k
Countries citing papers authored by Henry F. Chambers
This map shows the geographic impact of Henry F. Chambers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry F. Chambers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry F. Chambers more than expected).
Fields of papers citing papers by Henry F. Chambers
This network shows the impact of papers produced by Henry F. Chambers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry F. Chambers. The network helps show where Henry F. Chambers may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Henry F. Chambers, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 7 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 15 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 17 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 35 | |
| 11 | 2023 | 4 | |
| 12 | 2019 | 28 | |
| 13 | 2019 | 19 | |
| 14 | 2018 | 30 | |
| 15 | 2009 | 322 | |
| 16 | 2008 | 74 | |
| 17 | 2007 | 61 | |
| 18 | 2007 | 158 | |
| 19 | 2001 | 121 | |
| 20 | 1991 | 27 |
About Henry F. Chambers
Henry F. Chambers is a scholar working on Clinical Biochemistry, Applied Microbiology and Biotechnology and Molecular Medicine, having authored 257 papers that have together received 27.6k indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (170 papers), Bacterial Identification and Susceptibility Testing (92 papers), Antibiotic Resistance in Bacteria (55 papers), Infective Endocarditis Diagnosis and Management (53 papers), Antibiotics Pharmacokinetics and Efficacy (47 papers), Streptococcal Infections and Treatments (40 papers), Bacterial biofilms and quorum sensing (34 papers) and Antibiotic Use and Resistance (23 papers). The work is most often cited by research in Clinical Biochemistry (9.2k citations), Infectious Diseases (19.0k citations) and Applied Microbiology and Biotechnology (1.6k citations). Henry F. Chambers has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Frank R. DeLeo, Sheldon L. Kaplan, Catherine Liu, Arnold S. Bayer, C J Hackbarth, Michaël Otto, James C. Wade, Sherwood L. Gorbach, José G. Montoya and Jan V. Hirschmann. Their work appears in journals such as Nature, Science and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.